- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 15/10 - Drugs for genital or sexual disordersContraceptives for impotence
Patent holdings for IPC class A61P 15/10
Total number of patents in this class: 562
10-year publication summary
|
21
|
14
|
38
|
46
|
49
|
46
|
67
|
35
|
36
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17581 |
25 |
| Takeda Pharmaceutical Company Limited | 2707 |
9 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 824 |
8 |
| AstraZeneca AB | 2924 |
7 |
| ASKA Pharmaceutical Co., Ltd. | 100 |
7 |
| Banyu Pharmaceutical Co., Ltd. | 72 |
7 |
| Pfizer Inc. | 3371 |
6 |
| ATIR Holding S.A. | 18 |
6 |
| Kyowa Hakko Bio Co., Ltd. | 307 |
6 |
| Topadur Pharma AG | 22 |
6 |
| Topharman Shanghai Co., Ltd. | 55 |
5 |
| Initiator Pharma A/S | 16 |
5 |
| Activ'inside | 79 |
4 |
| Futura Medical Developments Limited | 28 |
4 |
| Nippon Shinyaku Co., Ltd. | 332 |
4 |
| Shionogi & Co., Ltd. | 860 |
4 |
| Sunshine Lake Pharma Co., Ltd. | 590 |
4 |
| Bristol-myers Squibb Company | 4872 |
3 |
| AstraZeneca UK Limited | 655 |
3 |
| Boehringer Ingelheim International GmbH | 4705 |
3 |
| Other owners | 436 |